Progyny (PGNY) Common Equity (2018 - 2026)

Progyny (PGNY) has 9 years of Common Equity data on file, last reported at $439.3 million in Q1 2026.

• Common Equity for Q1 2026 came in at $439.3 million, down 5.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $439.3 million (down 5.95% YoY), and the FY2025 annual result was $516.0 million, up 22.27% from the prior year.
• Common Equity fell to $439.3 million in Q1 2026 per PGNY's latest filing, from $516.0 million in the prior quarter.
• Over five years, Common Equity peaked at $571.6 million in Q1 2024 and troughed at $279.6 million in Q1 2022.
• A 5-year average of $450.6 million and a median of $456.2 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2024: Common Equity jumped 54.77% in 2022, then slipped 23.74% in 2024.
• A 5-year view of Common Equity shows it stood at $377.0 million in 2022, then jumped by 46.81% to $553.4 million in 2023, then fell by 23.74% to $422.1 million in 2024, then climbed by 22.27% to $516.0 million in 2025, then decreased by 14.86% to $439.3 million in 2026.
• Business Quant data shows PGNY's Common Equity at $439.3 million in Q1 2026, $516.0 million in Q4 2025, and $560.0 million in Q3 2025.